Donor Specific Regulation (DSR) Guided Tacrolimus Withdrawal to Myfortic Monotherapy in Liver Transplantation.

Trial Profile

Donor Specific Regulation (DSR) Guided Tacrolimus Withdrawal to Myfortic Monotherapy in Liver Transplantation.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 20 Jun 2014

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
    • 25 Jun 2012 Actual patient number is 10 according to ClinicalTrials.gov.
    • 25 Jun 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top